ASTH
Price
$23.11
Change
-$0.11 (-0.47%)
Updated
Nov 26, 04:16 PM (EDT)
Capitalization
1.16B
85 days until earnings call
Intraday BUY SELL Signals
SGRY
Price
$17.07
Change
+$0.19 (+1.12%)
Updated
Nov 26, 04:59 PM (EDT)
Capitalization
2.18B
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASTH vs SGRY

Header iconASTH vs SGRY Comparison
Open Charts ASTH vs SGRYBanner chart's image
Astrana Health
Price$23.11
Change-$0.11 (-0.47%)
Volume$300
Capitalization1.16B
Surgery Partners
Price$17.07
Change+$0.19 (+1.12%)
Volume$14.86K
Capitalization2.18B
ASTH vs SGRY Comparison Chart in %
ASTH
Daily Signal:
Gain/Loss:
SGRY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ASTH vs. SGRY commentary
Nov 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a StrongBuy and SGRY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 26, 2025
Stock price -- (ASTH: $23.22 vs. SGRY: $16.89)
Brand notoriety: ASTH and SGRY are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 93% vs. SGRY: 72%
Market capitalization -- ASTH: $1.16B vs. SGRY: $2.18B
ASTH [@Hospital/Nursing Management] is valued at $1.16B. SGRY’s [@Hospital/Nursing Management] market capitalization is $2.18B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $117.71B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 1 FA rating(s) are green whileSGRY’s FA Score has 0 green FA rating(s).

  • ASTH’s FA Score: 1 green, 4 red.
  • SGRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both ASTH and SGRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 4 TA indicator(s) are bullish while SGRY’s TA Score has 5 bullish TA indicator(s).

  • ASTH’s TA Score: 4 bullish, 7 bearish.
  • SGRY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SGRY is a better buy in the short-term than ASTH.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а +8.61% price change this week, while SGRY (@Hospital/Nursing Management) price change was +11.26% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +4.17%. For the same industry, the average monthly price growth was -5.21%, and the average quarterly price growth was +1.75%.

Reported Earning Dates

ASTH is expected to report earnings on Feb 19, 2026.

SGRY is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Hospital/Nursing Management (+4.17% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGRY($2.19B) has a higher market cap than ASTH($1.17B). SGRY has higher P/E ratio than ASTH: SGRY (2872.00) vs ASTH (122.21). SGRY YTD gains are higher at: -20.217 vs. ASTH (-26.356). SGRY has higher annual earnings (EBITDA): 522M vs. ASTH (112M). ASTH has more cash in the bank: 342M vs. SGRY (250M). ASTH has less debt than SGRY: ASTH (448M) vs SGRY (3.88B). SGRY has higher revenues than ASTH: SGRY (3.24B) vs ASTH (2.42B).
ASTHSGRYASTH / SGRY
Capitalization1.17B2.19B53%
EBITDA112M522M21%
Gain YTD-26.356-20.217130%
P/E Ratio122.212872.004%
Revenue2.42B3.24B75%
Total Cash342M250M137%
Total Debt448M3.88B12%
FUNDAMENTALS RATINGS
ASTH vs SGRY: Fundamental Ratings
ASTH
SGRY
OUTLOOK RATING
1..100
7454
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
8290
PRICE GROWTH RATING
1..100
8888
P/E GROWTH RATING
1..100
434
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASTH's Valuation (85) in the null industry is in the same range as SGRY (100) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.

ASTH's Profit vs Risk Rating (93) in the null industry is in the same range as SGRY (100) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.

ASTH's SMR Rating (82) in the null industry is in the same range as SGRY (90) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.

ASTH's Price Growth Rating (88) in the null industry is in the same range as SGRY (88) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.

ASTH's P/E Growth Rating (4) in the null industry is in the same range as SGRY (34) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to SGRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHSGRY
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
73%
Bearish Trend 10 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 6 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signal:
Gain/Loss:
SGRY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NDVAX17.680.38
+2.20%
MFS New Discovery Value A
MCBVX29.890.48
+1.63%
MFS Mid Cap Value B
PURAX20.57N/A
N/A
PGIM Global Real Estate A
PWDIX10.31N/A
N/A
DF Tactical Dividend Fund I
PGIRX26.04N/A
N/A
Polen Global Growth Investor

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
+2.74%
ACHC - ASTH
50%
Loosely correlated
+6.63%
DCGO - ASTH
40%
Loosely correlated
-0.49%
UHS - ASTH
31%
Poorly correlated
+2.87%
PNTG - ASTH
30%
Poorly correlated
+4.74%
SGRY - ASTH
30%
Poorly correlated
+3.68%
More